Hirano Keita, Komatsu Yasuhiro, Shimbo Takuro, Nakata Hirosuke, Kobayashi Daiki
Department of Nephrology, St Luke's International Hospital, Tokyo, Japan.
Department of Internal Medicine, Ohta Nishinouchi Hospital, Fukushima, Japan.
Clin Kidney J. 2022 Apr 26;15(9):1763-1769. doi: 10.1093/ckj/sfac107. eCollection 2022 Sep.
Evidence linking chronic kidney disease (CKD) and sleep duration is inconsistent. This study examined whether sleep duration is associated with a long-term risk of kidney function decline.
This retrospective, longitudinal cohort study included 82 001 participants who visited a primary care centre in Japan. Participants were categorized into CKD risk groups and sleep duration categories according to their self-reported average nightly sleep duration. The relationship between average nightly sleep duration and the incidence of composite renal outcome comprised a ≥40% reduction in estimated glomerular filtration rate (eGFR) from baseline and a decline in eGFR to <15 mL/min/1.73 m² was evaluated.
The mean age and eGFR (±standard deviation) of the patient cohort were 45.8 (±12.4) years and 81.8 (±15.4) mL/min/1.73 m², respectively. A total of 41 891 participants (51.1%) were women. During the median follow-up of 5.1 years [interquartile range 2.2-9.6], 4214 (5.1%) participants achieved the composite renal outcome. Only the long and very long sleep durations (≥8 h/night) were associated with an increased incidence of the composite renal outcome compared with the reference duration (7 h/night) [adjusted odds ratio (OR) 1.22 and 1.44; 95% confidence interval (CI) 1.09-1.36 and 1.13-1.84, for long and very long sleep durations, respectively]. Furthermore, this association was significant for both long and very long sleep durations in the low CKD risk group but only for long sleep duration in the intermediate CKD risk group. The results of the sex-specific analysis showed that men had a decreased risk of achieving the composite renal outcome (OR 0.91; 95% CI 0.79-1.06), while there was an increased risk for women (OR 1.14; 95% CI 1.02-1.28).
Average sleep durations ≥8 h/night were associated with an increased incidence of poor renal outcomes over time. However, a longitudinal cohort study is required to confirm whether sleep duration can prevent poor renal outcomes.
慢性肾脏病(CKD)与睡眠时间之间的关联证据并不一致。本研究探讨睡眠时间是否与肾功能下降的长期风险相关。
这项回顾性纵向队列研究纳入了82001名到日本一家初级保健中心就诊的参与者。根据参与者自我报告的平均夜间睡眠时间,将其分为CKD风险组和睡眠时间类别。评估平均夜间睡眠时间与复合肾脏结局发生率之间的关系,复合肾脏结局包括估计肾小球滤过率(eGFR)较基线降低≥40%以及eGFR降至<15 mL/min/1.73 m²。
患者队列的平均年龄和eGFR(±标准差)分别为45.8(±12.4)岁和81.8(±15.4)mL/min/1.73 m²。共有41891名参与者(51.1%)为女性。在中位随访5.1年[四分位间距2.2 - 9.6]期间,4214名(5.1%)参与者达到了复合肾脏结局。与参考睡眠时间(7小时/晚)相比,只有睡眠时间长和非常长(≥8小时/晚)与复合肾脏结局发生率增加相关[调整后的优势比(OR)分别为1.22和1.4;95%置信区间(CI)分别为1.09 - 1. 和1.13 - 1.84,对应睡眠时间长和非常长的情况]。此外,在低CKD风险组中,睡眠时间长和非常长均与复合肾脏结局显著相关,但在中度CKD风险组中仅睡眠时间长与复合肾脏结局显著相关有关。按性别分析的结果显示,男性达到复合肾脏结局的风险降低(OR 0.91;95% CI 0.79 - 1.06),而女性的风险增加(OR 1.14;95% CI 1.02 - 1.2)。
平均睡眠时间≥8小时/晚与肾功能不良结局的发生率随时间增加相关。然而,需要进行纵向队列研究以确认睡眠时间是否可预防肾功能不良结局。